Anterix (ATEX) EBITDA Margin (2016 - 2025)
Anterix's EBITDA Margin history spans 13 years, with the latest figure at 576.03% for Q4 2025.
- For Q4 2025, EBITDA Margin fell 102508.0% year-over-year to 576.03%; the TTM value through Dec 2025 reached 1407.47%, up 194324.0%, while the annual FY2025 figure was 185.94%, 3649.0% up from the prior year.
- EBITDA Margin reached 576.03% in Q4 2025 per ATEX's latest filing, down from 3909.47% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 3909.47% in Q3 2025 to a low of 6572.53% in Q2 2021.
- Average EBITDA Margin over 5 years is 1119.9%, with a median of 840.38% recorded in 2024.
- Peak YoY movement for EBITDA Margin: surged 580320bps in 2023, then plummeted -341233bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 3214.29% in 2021, then soared by 55bps to 1453.98% in 2022, then skyrocketed by 105bps to 76.24% in 2023, then soared by 489bps to 449.04% in 2024, then plummeted by -228bps to 576.03% in 2025.
- Per Business Quant, the three most recent readings for ATEX's EBITDA Margin are 576.03% (Q4 2025), 3909.47% (Q3 2025), and 1585.4% (Q2 2025).